ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,663Medicare Part D Prescriptions Filled, Including Refills

Rank: 108 out of 1454

$1.13M Total Retail Price of All Prescriptions

Rank: 54 out of 1454

913 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

2% of this provider’s 913 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

11% of this provider’s 913 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

4% of this provider’s 15,356 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$68 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

18 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 748 715 1 1
HYDROCHLOROTHIAZIDE 705 651 2 9
LISINOPRIL 682 666 3 4
AMLODIPINE BESYLATE 571 551 4 2
ATORVASTATIN CALCIUM 551 513 5 11
OMEPRAZOLE 525 452 6 3
LOSARTAN POTASSIUM 515 463 7 14
HYDROCODONE-ACETAMINOPHEN 486 404 S3 8 7
ATENOLOL 463 434 9 18
PANTOPRAZOLE SODIUM 389 359 10 31
PRAVASTATIN SODIUM 358 312 11 12
METFORMIN HCL 334 313 12 8
FUROSEMIDE 286 271 13 6
KLOR-CON 10 274 257 14 141
LEVOXYL 257 243 15 84
NOVOLOG MIX 70-30 FLEXPEN 251 241 16 211
SERTRALINE HCL 250 214 17 26
CLONIDINE HCL 222 216 18 49
GABAPENTIN 219 189 19 16
JANTOVEN 213 199 20 100
ZOLPIDEM TARTRATE 202 175 21 19
GLYBURIDE 181 169 R 22 98
NEXIUM 175 156 23 23
INDAPAMIDE 168 163 24 184
METOPROLOL TARTRATE 167 160 25 10
POTASSIUM CHLORIDE 165 153 26 15
CLOPIDOGREL 161 146 27 32
NIFEDIPINE ER 148 144 28 102
ADVAIR DISKUS 144 137 29 47
RANITIDINE HCL 129 122 30 43
METOPROLOL SUCCINATE 125 113 31 13
TRAMADOL HCL 118 105 32 20
TAMSULOSIN HCL 117 117 33 34
PLAVIX 115 107 34 45
CARVEDILOL 113 109 35 24
CRESTOR 110 99 36 22
PEN NEEDLE 109 102 37 113
ALLOPURINOL 107 104 38 28
MONOJECT INSULIN SYRINGE 104 92 39 312
PAROXETINE HCL 104 104 39 73
IBUPROFEN 103 78 41 107
FLUOXETINE HCL 102 83 42 72
TRIAMTERENE-HCTZ 98 90 43 44
SPIRIVA 93 79 44 52
DILTIAZEM 24HR CD 93 93 44 76
TRAZODONE HCL 92 88 46 50
ZOSTAVAX 92 91 46 195
AMITRIPTYLINE HCL 90 86 R 48 71
FLUNISOLIDE 87 81 49 411
CITALOPRAM HBR 85 83 50 21
ZOLPIDEM TARTRATE ER 84 73 51 300
VERAPAMIL ER 82 79 52 89
FLUTICASONE PROPIONATE 80 76 53 30
CYCLOBENZAPRINE HCL 77 58 R 54 59
TRAMADOL HCL-ACETAMINOPHEN 75 69 55 165
VENTOLIN HFA 72 71 56 112
ZETIA 72 60 56 69
AMOXICILLIN 71 62 58 133
GUANFACINE HCL 69 61 R 59 288
PROPRANOLOL HCL 69 69 59 129
DOXEPIN HCL 68 50 61 234
DONEPEZIL HCL 67 67 62 29
KLOR-CON M20 66 66 63 54
LEVOTHYROXINE SODIUM 64 54 64 5
POLYETHYLENE GLYCOL 3350 64 64 64 61
WARFARIN SODIUM 63 63 66 17
NAMENDA 61 61 67 48
ISOSORBIDE MONONITRATE ER 61 58 67 46
INDOMETHACIN 61 59 R 67 295
LOSARTAN-HYDROCHLOROTHIAZIDE 59 55 70 38
VYTORIN 58 58 71 170
LANSOPRAZOLE 57 41 72 140
LOVASTATIN 56 46 73 39
ACTOS 56 56 73 90
CELEBREX 56 47 73 81
COMBIVENT 55 55 76 115
MELOXICAM 53 41 77 37
LISINOPRIL-HYDROCHLOROTHIAZIDE 53 40 77 27
NORTRIPTYLINE HCL 52 52 79 257
SYMBICORT 52 52 79 143
LYRICA 52 49 79 103
NIASPAN 51 46 82 117
AZITHROMYCIN 51 48 82 42
DICLOFENAC SODIUM 50 35 84 118
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 17, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.